 | • レポートコード：MRC2012A6573 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学、材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、オリゴヌクレオチドAPIの世界市場を広く調査・分析し、今後の市場展望をまとめております。オリゴヌクレオチドAPIの種類別市場規模（アンチセンスオリゴヌクレオチドAPI、低分子干渉RNA（siRNA）API、MiRNA API、CpGオリゴヌクレオチドAPI、その他）、用途別市場規模（契約製造組織（CMO）、製薬会社）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Jazz Pharmaceuticals、Ajinomoto (GeneDesign)、Dynavax Technologies、Sarepta Therapeutics、Nitto Denko (Avecia)、Biogen、Alnylam Pharmaceuticals、Akcea Therapeutics、RiboBio ・地域別グローバル市場分析 2015年-2020年 ・オリゴヌクレオチドAPIの北米市場（アメリカ、カナダ、メキシコ） ・オリゴヌクレオチドAPIのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・オリゴヌクレオチドAPIのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・オリゴヌクレオチドAPIの南米市場（ブラジル、アルゼンチン） ・オリゴヌクレオチドAPIの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アンチセンスオリゴヌクレオチドAPI、低分子干渉RNA（siRNA）API、MiRNA API、CpGオリゴヌクレオチドAPI、その他 ・用途別分析：契約製造組織（CMO）、製薬会社 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Oligonucleotide API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Oligonucleotide API market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Oligonucleotide API market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oligonucleotide API market has been segmented into
Antisense Oligonucleotides API
Small Interfering RNA (siRNA) API
MiRNA API
CpG Oligonucleotides API
Others
By Application, Oligonucleotide API has been segmented into:
Contract Manufacturing Organizations (CMOs)
Pharmaceutical Companies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oligonucleotide API market presented in the report. This section sheds light on the sales growth of different regional and country-level Oligonucleotide API markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oligonucleotide API market.
The report offers in-depth assessment of the growth and other aspects of the Oligonucleotide API market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Oligonucleotide API Market Share Analysis
Oligonucleotide API competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oligonucleotide API sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oligonucleotide API sales, revenue and market share for each player covered in this report.
The major players covered in Oligonucleotide API are:
Jazz Pharmaceuticals
Ajinomoto (GeneDesign)
Dynavax Technologies
Sarepta Therapeutics
Nitto Denko (Avecia)
Biogen
Alnylam Pharmaceuticals
Akcea Therapeutics
RiboBio
Among other players domestic and global, Oligonucleotide API market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oligonucleotide API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oligonucleotide API, with price, sales, revenue and global market share of Oligonucleotide API in 2018 and 2019.
Chapter 3, the Oligonucleotide API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oligonucleotide API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Oligonucleotide API market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Oligonucleotide API sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Oligonucleotide API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oligonucleotide API Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Antisense Oligonucleotides API
1.2.3 Small Interfering RNA (siRNA) API
1.2.4 MiRNA API
1.2.5 CpG Oligonucleotides API
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Oligonucleotide API Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Contract Manufacturing Organizations (CMOs)
1.3.3 Pharmaceutical Companies
1.4 Overview of Global Oligonucleotide API Market
1.4.1 Global Oligonucleotide API Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Jazz Pharmaceuticals
2.1.1 Jazz Pharmaceuticals Details
2.1.2 Jazz Pharmaceuticals Major Business
2.1.3 Jazz Pharmaceuticals SWOT Analysis
2.1.4 Jazz Pharmaceuticals Product and Services
2.1.5 Jazz Pharmaceuticals Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ajinomoto (GeneDesign)
2.2.1 Ajinomoto (GeneDesign) Details
2.2.2 Ajinomoto (GeneDesign) Major Business
2.2.3 Ajinomoto (GeneDesign) SWOT Analysis
2.2.4 Ajinomoto (GeneDesign) Product and Services
2.2.5 Ajinomoto (GeneDesign) Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Dynavax Technologies
2.3.1 Dynavax Technologies Details
2.3.2 Dynavax Technologies Major Business
2.3.3 Dynavax Technologies SWOT Analysis
2.3.4 Dynavax Technologies Product and Services
2.3.5 Dynavax Technologies Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sarepta Therapeutics
2.4.1 Sarepta Therapeutics Details
2.4.2 Sarepta Therapeutics Major Business
2.4.3 Sarepta Therapeutics SWOT Analysis
2.4.4 Sarepta Therapeutics Product and Services
2.4.5 Sarepta Therapeutics Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Nitto Denko (Avecia)
2.5.1 Nitto Denko (Avecia) Details
2.5.2 Nitto Denko (Avecia) Major Business
2.5.3 Nitto Denko (Avecia) SWOT Analysis
2.5.4 Nitto Denko (Avecia) Product and Services
2.5.5 Nitto Denko (Avecia) Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biogen
2.6.1 Biogen Details
2.6.2 Biogen Major Business
2.6.3 Biogen Product and Services
2.6.4 Biogen Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Alnylam Pharmaceuticals
2.7.1 Alnylam Pharmaceuticals Details
2.7.2 Alnylam Pharmaceuticals Major Business
2.7.3 Alnylam Pharmaceuticals Product and Services
2.7.4 Alnylam Pharmaceuticals Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Akcea Therapeutics
2.8.1 Akcea Therapeutics Details
2.8.2 Akcea Therapeutics Major Business
2.8.3 Akcea Therapeutics Product and Services
2.8.4 Akcea Therapeutics Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 RiboBio
2.9.1 RiboBio Details
2.9.2 RiboBio Major Business
2.9.3 RiboBio Product and Services
2.9.4 RiboBio Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Oligonucleotide API Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Oligonucleotide API Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Oligonucleotide API Manufacturer Market Share in 2019
3.3.2 Top 6 Oligonucleotide API Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Oligonucleotide API Sales, Revenue and Market Share by Regions
4.1.1 Global Oligonucleotide API Sales and Market Share by Regions (2015-2020)
4.1.2 Global Oligonucleotide API Revenue and Market Share by Regions (2015-2020)
4.2 North America Oligonucleotide API Sales and Growth Rate (2015-2020)
4.3 Europe Oligonucleotide API Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Oligonucleotide API Sales and Growth Rate (2015-2020)
4.5 South America Oligonucleotide API Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Oligonucleotide API Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Oligonucleotide API Sales, Revenue and Market Share by Country
5.1.1 North America Oligonucleotide API Sales and Market Share by Country (2015-2020)
5.1.2 North America Oligonucleotide API Revenue and Market Share by Country (2015-2020)
5.2 United States Oligonucleotide API Sales and Growth Rate (2015-2020)
5.3 Canada Oligonucleotide API Sales and Growth Rate (2015-2020)
5.4 Mexico Oligonucleotide API Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Oligonucleotide API Sales, Revenue and Market Share by Country
6.1.1 Europe Oligonucleotide API Sales and Market Share by Country (2015-2020)
6.1.2 Europe Oligonucleotide API Revenue and Market Share by Country (2015-2020)
6.2 Germany Oligonucleotide API Sales and Growth Rate (2015-2020)
6.3 UK Oligonucleotide API Sales and Growth Rate (2015-2020)
6.4 France Oligonucleotide API Sales and Growth Rate (2015-2020)
6.5 Russia Oligonucleotide API Sales and Growth Rate (2015-2020)
6.6 Italy Oligonucleotide API Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Oligonucleotide API Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Oligonucleotide API Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Oligonucleotide API Revenue and Market Share by Regions (2015-2020)
7.2 China Oligonucleotide API Sales and Growth Rate (2015-2020)
7.3 Japan Oligonucleotide API Sales and Growth Rate (2015-2020)
7.4 Korea Oligonucleotide API Sales and Growth Rate (2015-2020)
7.5 India Oligonucleotide API Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Oligonucleotide API Sales and Growth Rate (2015-2020)
7.7 Australia Oligonucleotide API Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Oligonucleotide API Sales, Revenue and Market Share by Country
8.1.1 South America Oligonucleotide API Sales and Market Share by Country (2015-2020)
8.1.2 South America Oligonucleotide API Revenue and Market Share by Country (2015-2020)
8.2 Brazil Oligonucleotide API Sales and Growth Rate (2015-2020)
8.3 Argentina Oligonucleotide API Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Oligonucleotide API Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Oligonucleotide API Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Oligonucleotide API Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Oligonucleotide API Sales and Growth Rate (2015-2020)
9.3 Turkey Oligonucleotide API Sales and Growth Rate (2015-2020)
9.4 Egypt Oligonucleotide API Sales and Growth Rate (2015-2020)
9.5 South Africa Oligonucleotide API Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Oligonucleotide API Sales and Market Share by Type (2015-2020)
10.2 Global Oligonucleotide API Revenue and Market Share by Type (2015-2020)
10.3 Global Oligonucleotide API Price by Type (2015-2020)
11 Global Oligonucleotide API Market Segment by Application
11.1 Global Oligonucleotide API Sales Market Share by Application (2015-2020)
11.2 Global Oligonucleotide API Revenue Market Share by Application (2015-2020)
11.3 Global Oligonucleotide API Price by Application (2015-2020)
12 Market Forecast
12.1 Global Oligonucleotide API Sales, Revenue and Growth Rate (2021-2025)
12.2 Oligonucleotide API Market Forecast by Regions (2021-2025)
12.2.1 North America Oligonucleotide API Market Forecast (2021-2025)
12.2.2 Europe Oligonucleotide API Market Forecast (2021-2025)
12.2.3 Asia-Pacific Oligonucleotide API Market Forecast (2021-2025)
12.2.4 South America Oligonucleotide API Market Forecast (2021-2025)
12.2.5 Middle East & Africa Oligonucleotide API Market Forecast (2021-2025)
12.3 Oligonucleotide API Market Forecast by Type (2021-2025)
12.3.1 Global Oligonucleotide API Sales Forecast by Type (2021-2025)
12.3.2 Global Oligonucleotide API Market Share Forecast by Type (2021-2025)
12.4 Oligonucleotide API Market Forecast by Application (2021-2025)
12.4.1 Global Oligonucleotide API Sales Forecast by Application (2021-2025)
12.4.2 Global Oligonucleotide API Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Oligonucleotide API Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oligonucleotide API by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oligonucleotide API Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Oligonucleotide API Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Jazz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Jazz Pharmaceuticals Oligonucleotide API Major Business
Table 10. Jazz Pharmaceuticals Oligonucleotide API Total Revenue (USD Million) (2018-2019)
Table 11. Jazz Pharmaceuticals SWOT Analysis
Table 12. Jazz Pharmaceuticals Oligonucleotide API Product and Services
Table 13. Jazz Pharmaceuticals Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Ajinomoto (GeneDesign) Basic Information, Manufacturing Base and Competitors
Table 15. Ajinomoto (GeneDesign) Oligonucleotide API Major Business
Table 16. Ajinomoto (GeneDesign) Oligonucleotide API Total Revenue (USD Million) (2018-2019)
Table 17. Ajinomoto (GeneDesign) SWOT Analysis
Table 18. Ajinomoto (GeneDesign) Oligonucleotide API Product and Services
Table 19. Ajinomoto (GeneDesign) Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Dynavax Technologies Basic Information, Manufacturing Base and Competitors
Table 21. Dynavax Technologies Oligonucleotide API Major Business
Table 22. Dynavax Technologies Oligonucleotide API Total Revenue (USD Million) (2018-2019)
Table 23. Dynavax Technologies SWOT Analysis
Table 24. Dynavax Technologies Oligonucleotide API Product and Services
Table 25. Dynavax Technologies Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
Table 27. Sarepta Therapeutics Oligonucleotide API Major Business
Table 28. Sarepta Therapeutics Oligonucleotide API Total Revenue (USD Million) (2018-2019)
Table 29. Sarepta Therapeutics SWOT Analysis
Table 30. Sarepta Therapeutics Oligonucleotide API Product and Services
Table 31. Sarepta Therapeutics Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Nitto Denko (Avecia) Basic Information, Manufacturing Base and Competitors
Table 33. Nitto Denko (Avecia) Oligonucleotide API Major Business
Table 34. Nitto Denko (Avecia) Oligonucleotide API Total Revenue (USD Million) (2018-2019)
Table 35. Nitto Denko (Avecia) SWOT Analysis
Table 36. Nitto Denko (Avecia) Oligonucleotide API Product and Services
Table 37. Nitto Denko (Avecia) Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Biogen Basic Information, Manufacturing Base and Competitors
Table 39. Biogen Oligonucleotide API Major Business
Table 40. Biogen Oligonucleotide API Total Revenue (USD Million) (2018-2019)
Table 41. Biogen SWOT Analysis
Table 42. Biogen Oligonucleotide API Product and Services
Table 43. Biogen Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 45. Alnylam Pharmaceuticals Oligonucleotide API Major Business
Table 46. Alnylam Pharmaceuticals Oligonucleotide API Total Revenue (USD Million) (2018-2019)
Table 47. Alnylam Pharmaceuticals SWOT Analysis
Table 48. Alnylam Pharmaceuticals Oligonucleotide API Product and Services
Table 49. Alnylam Pharmaceuticals Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Akcea Therapeutics Basic Information, Manufacturing Base and Competitors
Table 51. Akcea Therapeutics Oligonucleotide API Major Business
Table 52. Akcea Therapeutics Oligonucleotide API Total Revenue (USD Million) (2018-2019)
Table 53. Akcea Therapeutics SWOT Analysis
Table 54. Akcea Therapeutics Oligonucleotide API Product and Services
Table 55. Akcea Therapeutics Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. RiboBio Basic Information, Manufacturing Base and Competitors
Table 57. RiboBio Oligonucleotide API Major Business
Table 58. RiboBio Oligonucleotide API Total Revenue (USD Million) (2018-2019)
Table 59. RiboBio SWOT Analysis
Table 60. RiboBio Oligonucleotide API Product and Services
Table 61. RiboBio Oligonucleotide API Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Global Oligonucleotide API Sales by Manufacturer (2018-2019) (Ton)
Table 63. Global Oligonucleotide API Revenue by Manufacturer (2018-2019) (USD Million)
Table 64. Global Oligonucleotide API Sales by Regions (2015-2020) (Ton)
Table 65. Global Oligonucleotide API Sales Market Share by Regions (2015-2020)
Table 66. Global Oligonucleotide API Revenue by Regions (2015-2020) (USD Million)
Table 67. North America Oligonucleotide API Sales by Countries (2015-2020) (Ton)
Table 68. North America Oligonucleotide API Sales Market Share by Countries (2015-2020)
Table 69. North America Oligonucleotide API Revenue by Countries (2015-2020) (USD Million)
Table 70. North America Oligonucleotide API Revenue Market Share by Countries (2015-2020)
Table 71. Europe Oligonucleotide API Sales by Countries (2015-2020) (Ton)
Table 72. Europe Oligonucleotide API Sales Market Share by Countries (2015-2020)
Table 73. Europe Oligonucleotide API Revenue by Countries (2015-2020) (USD Million)
Table 74. Asia-Pacific Oligonucleotide API Sales by Regions (2015-2020) (Ton)
Table 75. Asia-Pacific Oligonucleotide API Sales Market Share by Regions (2015-2020)
Table 76. Asia-Pacific Oligonucleotide API Revenue by Regions (2015-2020) (USD Million)
Table 77. South America Oligonucleotide API Sales by Countries (2015-2020) (Ton)
Table 78. South America Oligonucleotide API Sales Market Share by Countries (2015-2020)
Table 79. South America Oligonucleotide API Revenue by Countries (2015-2020) (USD Million)
Table 80. South America Oligonucleotide API Revenue Market Share by Countries (2015-2020)
Table 81. Middle East & Africa Oligonucleotide API Sales by Countries (2015-2020) (Ton)
Table 82. Middle East & Africa Oligonucleotide API Sales Market Share by Countries (2015-2020)
Table 83. Middle East & Africa Oligonucleotide API Revenue by Countries (2015-2020) (USD Million)
Table 84. Middle East & Africa Oligonucleotide API Revenue Market Share by Countries (2015-2020)
Table 85. Global Oligonucleotide API Sales by Type (2015-2020) (Ton)
Table 86. Global Oligonucleotide API Sales Share by Type (2015-2020)
Table 87. Global Oligonucleotide API Revenue by Type (2015-2020) (USD Million)
Table 88. Global Oligonucleotide API Revenue Share by Type (2015-2020)
Table 89. Global Oligonucleotide API Sales by Application (2015-2020) (Ton)
Table 90. Global Oligonucleotide API Sales Share by Application (2015-2020)
Table 91. Global Oligonucleotide API Sales Forecast by Regions (2021-2025) (Ton)
Table 92. Global Oligonucleotide API Market Share Forecast by Regions (2021-2025)
Table 93. Global Oligonucleotide API Sales Forecast by Type (2021-2025) (Ton)
Table 94. Global Oligonucleotide API Market Share Forecast by Type (2021-2025)
Table 95. Global Oligonucleotide API Sales Forecast by Application (2021-2025)
Table 96. Global Oligonucleotide API Market Share Forecast by Application (2021-2025)
Table 97. Direct Channel Pros & Cons
Table 98. Indirect Channel Pros & Cons
Table 99. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Oligonucleotide API Picture
Figure 2. Global Sales Market Share of Oligonucleotide API by Type in 2019
Figure 3. Antisense Oligonucleotides API Picture
Figure 4. Small Interfering RNA (siRNA) API Picture
Figure 5. MiRNA API Picture
Figure 6. CpG Oligonucleotides API Picture
Figure 7. Others Picture
Figure 8. Oligonucleotide API Sales Market Share by Application in 2019
Figure 9. Contract Manufacturing Organizations (CMOs) Picture
Figure 10. Pharmaceutical Companies Picture
Figure 11. Global Oligonucleotide API Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Oligonucleotide API Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Oligonucleotide API Sales Market Share by Manufacturer in 2019
Figure 32. Global Oligonucleotide API Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Oligonucleotide API Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Oligonucleotide API Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 37. Global Oligonucleotide API Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Oligonucleotide API Revenue Market Share by Regions (2015-2020)
Figure 39. Global Oligonucleotide API Revenue Market Share by Regions in 2018
Figure 40. North America Oligonucleotide API Sales and Growth Rate (2015-2020)
Figure 41. Europe Oligonucleotide API Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Oligonucleotide API Sales and Growth Rate (2015-2020)
Figure 43. South America Oligonucleotide API Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Oligonucleotide API Sales and Growth Rate (2015-2020)
Figure 45. North America Oligonucleotide API Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Oligonucleotide API Sales Market Share by Countries (2015-2020)
Figure 47. North America Oligonucleotide API Sales Market Share by Countries in 2018
Figure 48. North America Oligonucleotide API Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Oligonucleotide API Revenue Market Share by Countries in 2018
Figure 50. United States Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 51. Canada Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 52. Mexico Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 53. Europe Oligonucleotide API Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Oligonucleotide API Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Oligonucleotide API Revenue Market Share by Countries in 2019
Figure 56. Germany Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 57. UK Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 58. France Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 59. Russia Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 60. Italy Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 61. Asia-Pacific Oligonucleotide API Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Oligonucleotide API Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Oligonucleotide API Revenue Market Share by Regions 2019
Figure 64. China Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 65. Japan Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 66. Korea Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 67. India Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 68. Southeast Asia Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 69. South America Oligonucleotide API Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Oligonucleotide API Sales Market Share by Countries in 2019
Figure 71. South America Oligonucleotide API Revenue Market Share by Countries in 2019
Figure 72. Brazil Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 73. Argentina Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 74. Middle East and Africa Oligonucleotide API Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Oligonucleotide API Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Oligonucleotide API Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Oligonucleotide API Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 79. Egypt Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 80. Turkey Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 81. South Africa Oligonucleotide API Sales and Growth Rate (2015-2020) (Ton)
Figure 82. Global Oligonucleotide API Sales and Growth Rate (2021-2025) (Ton)
Figure 83. Global Oligonucleotide API Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Oligonucleotide API Market Forecast (2021-2025) (Ton)
Figure 85. Europe Sales Oligonucleotide API Market Forecast (2021-2025) (Ton)
Figure 86. Asia-Pacific Sales Oligonucleotide API Market Forecast (2021-2025) (Ton)
Figure 87. South America Sales Oligonucleotide API Market Forecast (2021-2025) (Ton)
Figure 88. Middle East & Africa Sales Oligonucleotide API Market Forecast (2021-2025) (Ton)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
オリゴヌクレオチド合成の世界市場（～2026年） Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the de…- オリゴヌクレオチド治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Oligonucleotide Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- オリゴヌクレオチドプールの世界市場（～2026年） Oligonucleotides are short DNA or RNA molecules, oligomers, that have a wide range of applications in genetic testing, research, and forensics. Commonly made in the laboratory by solid-phase chemical synthesis, these small bits of nucleic acids can be manufactured as single-stranded molecules with a…
- オリゴヌクレオチドの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Oligonucleotides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- アンチセンス・RNAi治療の世界市場（～2026年） Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (…